Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression—The Warburg effect revisited
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Glycoconjugate Journal
- Vol. 20 (5) , 353-364
- https://doi.org/10.1023/b:glyc.0000033631.35357.41
Abstract
Cell adhesion mediated by selectins and their carbohydrate ligands, sialyl Lewis X and sialyl Lewis A, figures heavily in cancer metastasis. Expression of these carbohydrate determinants is markedly enhanced in cancer cells, but the molecular mechanism that leads to cancer-associated expression of sialyl Lewis X/A has not been well understood. Results of recent studies indicated involvement of two principal mechanisms in the accelerated expression of sialyl Lewis X/A in cancers; ‘incomplete synthesis’ and ‘neosynthesis.’ As to ‘incomplete synthesis,’ we have recently found further modified forms of sialyl Lewis X and sialyl Lewis A in non-malignant colonic epithelium, which have additional 6-sulfation or 2 → 6 sialylation. The impairment of GlcNAc 6-sulfation and 2 → 6 sialylation upon malignant transformation leads to accumulation of sialyl Lewis X/A in colon cancer cells. Epigenetic changes such as DNA methylation and/or histone deacetylation are suggested to lie behind such incomplete synthesis. As to the mechanism called ‘neosynthesis,’ recent studies have indicated that cancer-associated alterations in the sugar transportation and intermediate carbohydrate metabolism play important roles. Cancer cells are known to exhibit a metabolic shift from oxidative to elevated anaerobic glycolysis (Warburg effect), which is correlated with the increased gene expression of sugar transporters and glycolytic enzymes induced by common cancer-specific genetic alterations. The increased sialyl Lewis X/A expression in cancer is a link in the chains of these events because our recent results indicated that these events accompany transcriptional induction of a set of genes closely related to its expression. Published in 2004.Keywords
This publication has 85 references indexed in Scilit:
- Transactivation of the fucosyltransferase VII gene by human T-cell leukemia virus type 1 Tax through a variant cAMP-responsive elementBlood, 2003
- Down‐regulation of Gal 3–O‐sulfotransferase‐2 (Gal3ST‐2) Expression in Human Colonic Non‐mucinous AdenocarcinomaJapanese Journal of Cancer Research, 2002
- Specificities ofN-Acetylglucosamine-6-O-sulfotransferases in Relation to L-selectin Ligand Synthesis and Tumor-associated Enzyme ExpressionJournal of Biological Chemistry, 2002
- β1,3-Galactosyltransferase β3Gal-T5 Acts on the GlcNAcβ1→3Galβ1→4GlcNAcβ1→R Sugar Chains of Carcinoembryonic Antigen and Other N-Linked Glycoproteins and Is Down-regulated in Colon AdenocarcinomasJournal of Biological Chemistry, 2001
- Molecular Cloning and Characterization of a Human β-Gal-3′-sulfotransferase That Acts on Both Type 1 and Type 2 (Galβ1–3/1–4GlcNAc-R) OligosaccharidesJournal of Biological Chemistry, 2001
- Cloning and Characterization of a Mammalian N-Acetylglucosamine-6-sulfotransferase That Is Highly Restricted to Intestinal TissueBiochemical and Biophysical Research Communications, 1999
- The α(1,3)Fucosyltransferase Fuc-TVII Controls Leukocyte Trafficking through an Essential Role in L-, E-, and P-selectin Ligand BiosynthesisCell, 1996
- Characterization of Two Glycolipid:α2-3Sialyltransferases, SAT-3 (CMP-NeuAc:nLcOse4Cer α2-3sialyltransferase) and SAT-4 (CMP-NeuAc:GgOse4Cer α2-3sialyltransferase), from Human Colon Carcinoma (Colo 205) Cell LineBiochemistry, 1996
- Biosynthesis in vitro of SA-Lex and SA-diLex by α1–3 fucosyltransferases from colon carcinoma cells and embryonic brain tissuesGlycobiology, 1991
- On the Origin of Cancer CellsScience, 1956